Parecoxib WB Powder for Solution for Injection 40 mg/vial
Product details
Registration number: SIN16913P
Classification: Prescription Only
Active ingredients: Parecoxib sodium eqv Parecoxib
Strength: 40mg/vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Registrant: ALMA-A PTE LTD
ATC code: M01AH04
HSA approval date: 14 December 2023
Manufacturer(s): Wanbang Biopharmaceuticals
Manufacturing country/countries: CHINA
What are the HSA registration number and classification for Parecoxib WB Powder for Solution for Injection 40 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16913P
Classification: Prescription Only
What active ingredients and strength are recorded for Parecoxib WB Powder for Solution for Injection 40 mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Parecoxib sodium eqv Parecoxib
Strength: 40mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Parecoxib WB Powder for Solution for Injection 40 mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Who is the recorded registrant for Parecoxib WB Powder for Solution for Injection 40 mg/vial?
Which manufacturers and countries are listed for Parecoxib WB Powder for Solution for Injection 40 mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Wanbang Biopharmaceuticals
Manufacturing country/countries: CHINA
Where can I look up Parecoxib WB Powder for Solution for Injection 40 mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16913P or the exact product name Parecoxib WB Powder for Solution for Injection 40 mg/vial. The general register link does not preselect this product.
What are the source dates for this Parecoxib WB Powder for Solution for Injection 40 mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Parecoxib WB Powder for Solution for Injection 40 mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16913P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)